BOSTON — The Cannabis Control Commission could review as many as seven more recreational marijuana licenses on Thursday.
The CCC will meet Thursday and plans to review seven cultivation, retailer, and manufacturer licenses for Alternative Therapies Group, Inc. and New England Treatment Access.
So far, the state has yet to approve any licenses for testing laboratories and recreational marijuana sales cannot begin in the state until that happens. All marijuana needs to be tested for contaminants at the labs before it can be sold to the public.
Recreational sales were supposed to begin July 1.
Cox Media Group